4553.Tライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 15:15):

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan...

Stats
本日の出来高	94 800.00
平均出来高	167 551
時価総額	136.48B
EPS	¥0 ( 2024-02-12 )
次の収益日	( ¥38.66 ) 2024-05-12
Last Dividend	¥30.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	11.63
ATR14	¥1.288 (0.05%)

ボリューム相関

長: -0.07 (neutral)

短: -0.30 (neutral)

Signal:(59.213) Neutral

Towa Pharmaceutical Co., 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Towa Pharmaceutical Co., 相関 - 通貨/商品

0.23
( neutral )

0.73
( moderate )

0.18
( neutral )

0.35
( neutral )

-0.13
( neutral )

-0.58
( weak negative )

Towa Pharmaceutical Co., 財務諸表

Annual	2022
収益:	¥208.86B
総利益:	¥72.71B (34.81 %)
EPS:	¥44.72

FY	2022
収益:	¥208.86B
総利益:	¥72.71B (34.81 %)
EPS:	¥44.72

FY	2022
収益:	¥165.62B
総利益:	¥70.19B (42.38 %)
EPS:	¥323.36

FY	2021
収益:	¥154.90B
総利益:	¥65.45B (42.25 %)
EPS:	¥283.62

Financial Reports:

No articles found.

Towa Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥30.00 (N/A)	¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Towa Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.41%) | Divividend Growth Potential Score: 4.05 - Stable (19.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.667	2005-03-28
Last Dividend	¥30.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	38	--
Total Paid Out	¥541.50	--
Avg. Dividend % Per Year	0.00%	--
Score	3.37	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.05
Div. Directional Score	6.64	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.27 %

Dividend Stability

0.10 Bad

Dividend Score

3.37

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8068.T	Ex Dividend Knight	2024-01-30	Semi-Annually	0.00%
7350.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6590.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
5936.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4617.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3852.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
3093.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
1967.T	Ex Dividend Junior	2024-03-18	Annually	0.00%
9531.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8424.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0496	1.500	9.01	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0283	1.200	9.06	10.00	[0 - 0.3]
returnOnEquityTTM	0.0814	1.500	-0.207	-0.310	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.77	0.800	1.148	0.919	[1 - 3]
quickRatioTTM	1.173	0.800	7.81	6.25	[0.8 - 2.5]
cashRatioTTM	0.399	1.500	8.89	10.00	[0.2 - 2]
debtRatioTTM	0.473	-1.500	2.12	-3.17	[0 - 0.6]
interestCoverageTTM	16.44	1.000	5.02	5.02	[3 - 30]
operatingCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	1.318	-1.500	4.73	-7.09	[0 - 2.5]
grossProfitMarginTTM	0.347	1.000	7.56	7.56	[0.2 - 0.8]
operatingProfitMarginTTM	0.0564	1.000	-0.871	-0.871	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.206	1.000	9.97	9.97	[0.2 - 2]
assetTurnoverTTM	0.571	0.800	9.53	7.62	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.63	1.000	8.93	0	[1 - 100]
returnOnEquityTTM	0.0814	2.50	-0.133	-0.310	[0.1 - 1.5]
freeCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.16	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.135	1.500	-4.23	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.23	0	[0.1 - 0.5]
Total Score				4.05

Towa Pharmaceutical Co.,

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.